Skip to main content
Year archive

aap Implantate AG — 2020 filings

All 32 regulatory filings released by aap Implantate AG (AAQ1) in 2020, sourced directly from the official regulator.

32 Filings
2020 Period
2020 filings (32)
Filing Released Lang
aap completes Management Board transition to support growth and value creation
Board/Management Information
2020-12-18 English
aap's successful restructuring paves way for follow-up steps in multilayered financing for growth and value creation
Capital/Financing Update
2020-12-08 English
Q3 and 9M/2020: aap restructuring shows clear successes in challenging COVID-19 times
Earnings Release 9M 2020
2020-10-30 English
aap Implantate AG: Significant year-on-year improvement in Q3/2020 earnings with almost balanced EBITDA - EBITDA forecast for the full year raised
Earnings Release 9M 2020
2020-10-26 English
aap: General data for bank technical implementation of ordinary capital reduction
Share Issue/Capital Change
2020-10-21 English
Veroffentlichung gema 50 WpHG mit dem Ziel der europaweiten Verbreitung
Share Issue/Capital Change
2020-10-21 German
Q3/2020: Capital reduction successfully implemented; sales in Q3/2020 almost stable despite continued negative impact of COVID-19; strong growth in US business (+68%) and recovery tendencies in Europe
Earnings Release 9M 2020
2020-10-09 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-10-06 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-10-06 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2020-09-08 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Annual Report FY 2019
2020-09-01 German
aap's convertible bond oversubscribed
Capital/Financing Update
2020-08-27 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2020-08-25 English
Q2 and H1/2020: Tangible positive impact of restructuring on aap performance in challenging COVID-19 times
Earnings Release H1 2020
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2020-08-14 English
Halbjahresfinanzbericht
Interim / Quarterly Report H1 2020
2020-08-14 German
Halbjahresfinanzbericht 2020
Interim / Quarterly Report H2 2020
2020-08-14 German
Report Publication Announcement 2020
Report Publication Announcement
2020-08-12 English
Datum:12.08.2020
Report Publication Announcement
2020-08-12 German
aap Implantate AG offers its shareholders a convertible bond with a total nominal value of EUR 2.6 million; attractive offer and a major step toward securing the company's continued existence
Capital/Financing Update
2020-08-05 English
Sales Q2/2020 and H1/2020: Continued dynamic development in the U.S. with double-digit growth rates; international and German business strongly impacted by COVID-19 pandemic
Earnings Release H1 2020
2020-08-03 English
Jahresfinanzbericht 2019
Annual Report FY 2019
2020-08-03 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Annual Report FY 2019
2020-07-24 German
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 07.08.2020 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2020-07-16 German
Report Publication Announcement 2020
Report Publication Announcement
2020-06-28 English
Datum:28.06.2020
Report Publication Announcement
2020-06-28 German
aap Implantate AG: Postponement of publication of annual financial statements 2019 and annual general meeting 2020
Report Publication Announcement
2020-04-29 English
aap receives approval from ethics commissions for human clinical study for innovative antibacterial silver coating technology; all regulatory requirements for starting study in Germany fulfilled
Regulatory Filings
2020-04-23 English
aap Implantate AG resolves on concept for extensive staff reduction and extraordinary value adjustment to capitalized development costs; postponement of publication of the 2019 financial statements
Major Shareholding Notification
2020-03-16 English